课题基金 / 基金详情

PhD Training Program in Virology and Gene Therapy

PhD Training Program in Virology and Gene Therapy
病毒学和基因治疗博士培训项目
批准号:
10711192
负责人:
ROBERTO B. CATTANEO
金额:
$15.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-08-15 至 2028-07-31

项目摘要

项目成果

ROBERTO B. CATTANEO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Unifying scientific principles in the life sciences continue to be discovered in viral systems. Gene therapy and oncolytic virotherapy depend on viral vectors. Awareness that a deep understanding of fundamental virology is necessary for the development of gene therapy led to the foundation of the Virology and Gene Therapy (VGT) track of Mayo Clinic Graduate School of Biomedical Sciences (MCGSBS) in 2004; since 2018 the NIH supports three of its best pre-doctoral students. Ph.D. training leverages the strength of basic research and the robust translational infrastructure at Mayo Clinic. Training is performed in the laboratories of 22 VGT faculty members. Eight are from the Department of Molecular Medicine, three from Medical Oncology, two each from Infectious Diseases, Hematology, and Biochemistry/Molecular Biology. The others are from five different departments. The faculty is united by leadership in research on viruses, vectors, mechanisms of human disease, cancer treatment, and gene therapy. VGT popularity is based in part on its unique training opportunities in both virology and the translation of viral and gene therapeutics. During the entire time of their thesis the students engage in a full array of programmatic activities including journal clubs, seminar series, an annual retreat and national scientific meetings. Requirements for the VGT track conform to the general requirements of MCGSBS. Continued NIH support of three trainees would allow further development of this successful and innovative program.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fped.2023.1305657
发表时间: 2023
期刊: Frontiers in pediatrics
影响因子: 2.6
作者: []
通讯作者:
DOI: 10.1016/j.antiviral.2022.105291
发表时间: 2022-04
期刊: Antiviral research
影响因子: 7.6
作者: []
通讯作者:
DOI: 10.1038/s41417-022-00431-y
发表时间: 2022-08
期刊: CANCER GENE THERAPY
影响因子: 6.4
作者: [Budzik, Karol M., Nace, Rebecca A., Ikeda, Yasuhiro, Russell, Stephen J.]
通讯作者: Russell, Stephen J.
DOI: 10.1016/j.antiviral.2020.104993
发表时间: 2021-01
期刊: Antiviral research
影响因子: 7.6
作者: [Mendoza CA, Yamaoka S, Tsuda Y, Matsuno K, Weisend CM, Ebihara H]
通讯作者: Ebihara H
Lethal human brain infection by measles virus: phylogeography and mechanisms
  • 批准号:
    10190204
  • 项目类别:
  • 资助金额:
    $25.01万
  • 财政年份:
    2021
  • 负责人:
    ROBERTO B. CATTANEO
  • 依托单位:
Lethal human brain infection by measles virus: phylogeography and mechanisms
  • 批准号:
    10390369
  • 项目类别:
  • 资助金额:
    $20.1万
  • 财政年份:
    2021
  • 负责人:
    ROBERTO B. CATTANEO
  • 依托单位:
Intercellular transfer of cytoplasm and measles virus through nectins
  • 批准号:
    10250302
  • 项目类别:
  • 资助金额:
    $49.05万
  • 财政年份:
    2020
  • 负责人:
    ROBERTO B. CATTANEO
  • 依托单位:
Intercellular transfer of cytoplasm and measles virus through nectins
  • 批准号:
    10687193
  • 项目类别:
  • 资助金额:
    $49.05万
  • 财政年份:
    2020
  • 负责人:
    ROBERTO B. CATTANEO
  • 依托单位:
海外基金